Steve Borzak, MD By Steve Borzak, MD, FACC The British Medical Journal published several papers this week detailing concerns about the bleeding risk of pradaxa (dabigatran), a coumadin substitute used for stroke risk reduction in atrial fibrillation. In the first article, investigative journalist Deborah Cohen…